CANCER METAST REV 润色咨询

CANCER AND METASTASIS REVIEWS

出版年份:1982 年文章数:878 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:1.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=44ee1321, cover=https://img.medsci.cn/images/journal/cover/2021/alD_202109271314373370.jpg, fullname=CANCER AND METASTASIS REVIEWS, abbr=CANCER METAST REV, pyear=1982, frequence=Quarterly, articleNumbers=878, citedSelf2015=1.7, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=0167-7659, greenSci=https://www.greensci.net/search?kw=0167-7659, scijournal=https://www.scijournal.org/impact-factor-of-CANCER-METAST-REV.shtml, medsciHotlightString=null, medsciHotlightRealtime=2.39, medsciHotlight=3.048, medsciHotlight5year=4.33452, citescore=10.7, hIndex=148, impactFactor=9.2, orgnization=Springer Netherlands, orgnizationUrl=http://springerlink.com, country=Netherlands, countryCn=荷兰, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|BIOSIS Previews|BIOSIS Reviews Reports And Meetings, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=https://link.springer.com/journal/10555, websiteHits=6737, guideForAuthor=null, guideForAuthorHits=8, submitWebsite=投稿邮箱:Avraham Raz: raza@karmanos.org 还有Kenneth V. Honn: k.v.honn@wayne.edu, submitWebsiteHits=1872, content=Contemporary biomedical research is on the threshold of an era in which physiological and pathological processes can be analyzed in increasingly precise and mechanistic terms. The transformation of biology from a largely descriptive phenomenological discipline to one in which the regulatory principles can be understood and manipulated with predictability brings a new dimension to the study of cancer and the search for effective therapeutic modalities for this disease. Cancer and Metastasis Reviews provides a forum for critical review and discussion of these challenging developments. Each issue of Cancer and Metastasis Reviews is devoted to a particular theme or topic and will contain from five to seven different contributions. In addition an introductory preface is included from an individual who is distinguished in the field to be covered. The topics and contributors are chosen by the Editor-in-Chief after consultation with various members of the Editorial Advisory Board. Special emphasis is placed on subjects which are of relevance to the molecular and cellular biology of cancer metastasis and tumor progression as well as to the treatment of metastatic disease. Occasional issues will be devoted to an in-depth clinical and biological analysis of a particular type of cancer. A major function of the journal is to review some of the more important and interesting recent developments in the biology and treatment of malignant disease as well as to highlight new and promising directions be they technological or conceptual. Contributors are encouraged to review their personal work and be speculative., totalCites=8081, brief=CANCER METAST REV杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=肿瘤学" >肿瘤学</a></strong>”子行业的优秀级杂志, articleType=本刊可能只接收综述类文章或很多文章不被WOS收录, medsciHeat=黑红, medsciComment=CANCER METAST REV在该细分领域可能是一流杂志,可能是创刊时间短或不是热门学科,整体来说,国内学者关注度仍然不够。对于投稿而言,建议多向"&abbr&"投稿,当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=44ee1321'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=2), ImpactFactorTagDto(id=3184, tagName=综述, createdHits=1), ImpactFactorTagDto(id=5431, tagName=肿瘤转移, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=5.48), GetImpactFactorCiteScoreListResponse(year=2017, citescore=5.4), GetImpactFactorCiteScoreListResponse(year=2018, citescore=5.75), GetImpactFactorCiteScoreListResponse(year=2019, citescore=10.1), GetImpactFactorCiteScoreListResponse(year=2020, citescore=10.7)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=4.071), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=3.121), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=3.095), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=2.686), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=2.39)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=28/321), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=26/191)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=ONCOLOGY, rank=Q1)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0167-7659[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=CANCER AND METASTASIS REVIEWS[ta], article_number=55, article_number_cn=1, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
CANCER METAST REV/CANCER AND METASTASIS REVIEWS
ISSN
0167-7659
影响指数话题
预警等级
MedSci期刊指数
2.39 (MedSci实时期刊指数) | 4.33452 (5年期刊指数)
CiteScore值
10.7
h-index
148
h5-median
暂无数据
出版社/管理机构
杂志由 Springer Netherlands 出版或管理
出版国家/地区
Netherlands 荷兰
出版周期
Quarterly
出版年份
1982
是否OA
被收录情况
Science Citation Index|Science Citation Index Expanded|BIOSIS Previews|BIOSIS Reviews Reports And Meetings
JCR分区
ONCOLOGY Q1
中科院分区
大类:医学 2区
小类:医学 2 区